The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.
about
Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programmePhase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.Tolerability of gefitinib in patients receiving treatment in everyday clinical practiceThe role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs.Yeast as a model system for anticancer drug discovery.Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.Gefitinib: a consideration of cost.A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors.
P2860
Q24805211-4F60AA12-88D5-4386-AE71-3212F43A691BQ34168530-1476C2DA-BF63-45C7-AD18-491EC9AE7B51Q35602194-D0A6F7EC-0413-40B4-81AD-FD7A612B5BFFQ35740281-E67004BD-6C9D-4309-9FAF-777FAC5D01D5Q36181404-78DF2CB2-9D31-459E-B619-97A7376569B7Q37152009-4D8413A4-72FA-499D-9C48-749CF60521B2Q37196395-DB3E7805-C49A-4D84-A36C-9E5336B22511Q37320501-AA07C971-861B-4433-A429-B60F64CF61FCQ39052926-9C4CB67F-A16A-4206-AF3C-368AC11D890EQ43042819-3C3C20C5-99BB-479E-9B31-0A569BA7FF0CQ54382839-8FC41217-8ED5-4CCC-93E6-AD7BA460438B
P2860
The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
type
label
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
prefLabel
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
P1433
P1476
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
P2093
Rowinsky EK
P304
1-14; discussion 41-2
P356
10.2165/00003495-200060001-00001
P478
60 Suppl 1
P577
2000-01-01T00:00:00Z
P6179
1041179612